title: Predicting resistance to dasatinib therapy for patients with Philadelphia-positive leukemia with prior tyrosine kinase inhibitor failure.
authors.affiliation: Northwestern Medicine Developmental Therapeutics Institute, Northwestern University , Chicago, IL , USA.
authors.forename: Jason B
authors.initials: JB
authors.lastname: Kaplan
authors.forename: Leonidas C
authors.initials: LC
authors.lastname: Platanias
authors.forename: Francis J
authors.initials: FJ
authors.lastname: Giles
mesh_terms: D000069439:Dasatinib / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000235:genetics*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D009154:Mutation / Q000235:genetics*
chemical_list: D016044:Fusion Proteins, bcr-abl; D000069439:Dasatinib